Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E34.59 EPS (ttm)6.65 Insider Own11.30% Shs Outstand907.30M Perf Week-3.92%
Market Cap220.57B Forward P/E27.13 EPS next Y8.48 Insider Trans-1.86% Shs Float857.10M Perf Month-14.31%
Income6.07B PEG2.34 EPS next Q1.97 Inst Own85.10% Short Float0.72% Perf Quarter5.28%
Sales26.73B P/S8.25 EPS this Y36.90% Inst Trans1.31% Short Ratio2.25 Perf Half Y24.86%
Book/sh7.10 P/B32.41 EPS next Y7.58% ROA13.10% Target Price261.75 Perf Year50.91%
Cash/sh3.41 P/C67.43 EPS next 5Y14.80% ROE102.00% 52W Range129.21 - 275.87 Perf YTD36.28%
Dividend3.40 P/FCF82.28 EPS past 5Y24.60% ROI22.60% 52W High-16.59% Beta0.27
Dividend %1.48% Quick Ratio0.90 Sales past 5Y4.20% Gross Margin74.30% 52W Low78.08% ATR5.56
Employees35000 Current Ratio1.10 Sales Q/Q22.60% Oper. Margin21.80% RSI (14)24.54 Volatility2.39% 2.14%
OptionableYes Debt/Eq2.56 EPS Q/Q-1.50% Profit Margin22.70% Rel Volume1.60 Prev Close231.04
ShortableYes LT Debt/Eq2.29 EarningsAug 03 BMO Payout47.60% Avg Volume2.73M Price230.10
Recom2.20 SMA20-9.39% SMA50-8.44% SMA20010.55% Volume4,376,150 Change-0.41%
Aug-05-21Upgrade DZ Bank Hold → Buy $288
Jul-27-21Resumed Truist Buy $262
Jun-24-21Reiterated Cantor Fitzgerald Overweight $245 → $300
Jan-19-21Upgrade Mizuho Neutral → Buy $164 → $222
Dec-10-20Upgrade Wolfe Research Peer Perform → Outperform $147 → $183
Nov-10-20Resumed Bernstein Mkt Perform $150
Sep-29-20Initiated Berenberg Hold $144
Sep-03-20Upgrade Morgan Stanley Equal-Weight → Overweight $176
Jun-16-20Upgrade Guggenheim Neutral → Buy
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Sep-17-21 10:11AM  
07:40AM  
Sep-16-21 03:56PM  
03:55PM  
03:30PM  
11:28AM  
Sep-15-21 08:33AM  
07:57AM  
07:38AM  
07:27AM  
06:53AM  
06:45AM  
Sep-13-21 02:52PM  
10:00AM  
08:00AM  
Sep-11-21 06:01AM  
Sep-10-21 01:06PM  
08:12AM  
Sep-09-21 04:42PM  
04:16PM  
02:00PM  
08:00AM  
06:58AM  
Sep-07-21 09:00AM  
06:00AM  
Sep-04-21 11:12AM  
Sep-03-21 10:00AM  
Sep-02-21 03:04PM  
11:31AM  
09:17AM  
08:34AM  
Sep-01-21 05:50PM  
04:05PM  
02:39PM  
Aug-31-21 02:00PM  
01:25PM  
01:23PM  
Aug-30-21 01:30PM  
11:43AM  
Aug-29-21 11:00AM  
Aug-27-21 06:50PM  
06:02PM  
02:05PM  
11:25AM  
09:00AM  
Aug-25-21 06:45AM  
06:45AM  
12:39AM  
Aug-20-21 02:34PM  
08:23AM  
08:03AM  
Aug-19-21 09:36AM  
Aug-18-21 02:08PM  
02:02PM  
01:30PM  
09:24AM  
07:37AM  
Aug-17-21 10:11AM  
10:08AM  
08:28AM  
06:58AM  
06:30AM  
Aug-16-21 05:18PM  
08:24AM  
08:12AM  
07:00AM  
02:00AM  
Aug-13-21 12:30AM  
Aug-11-21 06:04AM  
Aug-10-21 05:37PM  
Aug-07-21 03:48AM  
Aug-06-21 12:31PM  
10:45AM  
10:20AM  
10:05AM  
09:30AM  
Aug-05-21 12:32PM  
10:09AM  
Aug-04-21 03:07PM  
06:31AM  
Aug-03-21 05:01PM  
04:08PM  
12:21PM  
11:01AM  
09:42AM  
09:01AM  
07:35AM  
06:44AM  
06:38AM  
06:31AM  
06:29AM  
06:25AM  
06:00AM  
05:50AM  
03:59AM  
02:36AM  
12:38AM  
Aug-02-21 06:18PM  
11:53AM  
09:36AM  
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceuticals worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; and MiNA Therapeutics Limited. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerAug 18Sale274.3115,4304,232,603108,248,610Aug 19 11:35 AM
LILLY ENDOWMENT INC10% OwnerAug 17Sale274.083,060838,698108,264,040Aug 18 01:20 PM
LILLY ENDOWMENT INC10% OwnerAug 09Sale267.50104,71128,010,135108,267,100Aug 10 03:48 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale264.057,5972,005,965108,371,811Aug 09 12:58 PM
LILLY ENDOWMENT INC10% OwnerAug 05Sale264.26132,69235,065,320108,379,408Aug 06 12:57 PM
LILLY ENDOWMENT INC10% OwnerAug 04Sale265.1513,4583,568,360108,512,100Aug 05 03:52 PM
LILLY ENDOWMENT INC10% OwnerAug 03Sale256.12236,54260,582,474108,525,558Aug 04 03:15 PM
LILLY ENDOWMENT INC10% OwnerJul 21Sale237.0086,11120,408,307108,762,100Jul 22 10:47 AM
LILLY ENDOWMENT INC10% OwnerJul 20Sale237.0615,6103,700,429108,848,211Jul 21 11:12 AM
LILLY ENDOWMENT INC10% OwnerJul 14Sale237.0210,7802,555,119108,863,821Jul 15 02:03 PM
LILLY ENDOWMENT INC10% OwnerJul 12Sale237.093,238767,694108,874,601Jul 13 03:08 PM
LILLY ENDOWMENT INC10% OwnerJul 09Sale237.39109,26125,937,091108,877,839Jul 12 12:58 PM
LILLY ENDOWMENT INC10% OwnerJul 06Sale235.09210,00049,369,047108,987,100Jul 07 09:17 AM
LILLY ENDOWMENT INC10% OwnerJul 02Sale232.94202,10247,077,749109,197,100Jul 06 01:05 PM
LILLY ENDOWMENT INC10% OwnerJun 24Sale237.5112,8983,063,401109,399,202Jun 25 01:16 PM
LILLY ENDOWMENT INC10% OwnerJun 10Sale233.63240,00056,072,352109,412,100Jun 11 10:35 AM
LILLY ENDOWMENT INC10% OwnerJun 09Sale224.93220,00049,484,263109,652,100Jun 10 03:35 PM
LILLY ENDOWMENT INC10% OwnerJun 07Sale224.72230,00051,685,008109,872,100Jun 08 03:16 PM
LILLY ENDOWMENT INC10% OwnerMay 24Sale202.277,3291,482,405110,102,100May 25 10:39 AM
LILLY ENDOWMENT INC10% OwnerMay 21Sale200.5892,74018,602,006110,109,429May 24 11:15 AM
LILLY ENDOWMENT INC10% OwnerMay 20Sale200.4899,93120,033,767110,202,169May 21 12:57 PM
TAI JACKSON PDirectorApr 30Buy182.841,366249,75961,195May 03 07:01 PM
Zakrowski Donald AChief Accounting OfficerApr 28Sale181.383,000544,1405,987Apr 29 08:31 PM
LILLY ENDOWMENT INC10% OwnerMar 09Sale209.7959,95912,579,032110,302,100Mar 10 02:59 PM
LILLY ENDOWMENT INC10% OwnerMar 08Sale209.69125,28426,271,092110,362,059Mar 09 12:26 PM
Hakim AnatSVP, GC & SecretaryMar 01Option Exercise0.007,92807,928Mar 03 05:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.005,445027,425Feb 03 06:29 PM
Shah Aarti S.SVP & CIDOFeb 01Option Exercise0.006,282023,369Feb 03 07:02 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0075,3870343,639Feb 03 06:57 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Feb 01Option Exercise0.006,282010,592Feb 03 06:51 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.0012,146056,919Feb 03 06:43 PM
Norton JohnaSenior VP, Global QualityFeb 01Option Exercise0.003,435020,953Feb 03 06:38 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0015,0780115,289Feb 03 06:33 PM
Smiley Joshua LSVP and CFOFeb 01Option Exercise0.0019,266060,702Feb 03 08:22 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,754035,400Feb 03 07:26 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale190.80215,00041,022,862110,487,343Jan 19 01:04 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale185.97210,00039,053,064110,702,343Jan 14 11:23 AM
LILLY ENDOWMENT INC10% OwnerJan 11Sale185.49220,00040,807,754110,912,343Jan 12 11:27 AM
Smiley Joshua LSVP and CFOOct 01Option Exercise0.007,947044,918Oct 05 12:19 PM